Ethnicity and the diagnosis gap in liver disease: a population-based study - PubMed (original) (raw)

Ethnicity and the diagnosis gap in liver disease: a population-based study

William Alazawi et al. Br J Gen Pract. 2014 Nov.

Abstract

Background: Liver disease is a major cause of morbidity and mortality worldwide. Large numbers of liver function tests (LFTs) are performed in primary care, with abnormal liver biochemistry a common finding. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. Metabolic syndrome, common in people from South Asia, is an important risk factor for NAFLD.

Aim: It is hypothesised that a large gap exists between numbers of patients with abnormal LFTs and those with recorded liver diagnoses, and that NAFLD is more common among adults of South Asian ethnic groups.

Design and setting: A cross-sectional study of 690,683 adults in coterminous general practices in a region with high ethnic diversity.

Method: Data were extracted on LFTs, liver disease, and process of care measures from computerised primary care medical records.

Results: LFTs were performed on 218,032 patients, of whom 31 627 had elevated serum transaminases. The prevalence of abnormal LFTs was highest among individuals of Bangladeshi ethnicity. Of the patients with abnormal LFTs, 88.4% did not have a coded liver diagnosis. NAFLD was the most frequently recorded liver disease and was most common among Bangladeshi patients. In a multivariate analysis, independent risk factors for NAFLD included Bangladeshi ethnicity, diabetes, raised BMI, hypertension, and hypercholesterolaemia.

Conclusion: Abnormal LFTs are common in the population, but are underinvestigated and often remain undiagnosed. Bangladeshi ethnicity is an important independent risk factor for NAFLD.

Keywords: NAFLD; ethnicity; liver; liver disease; population.

© British Journal of General Practice 2014.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Venn diagram showing patients with abnormal liver tests and most commonly recorded liver diagnoses. (A+B+C+D) = All adults tested (n = 218 032); Set A = Tested and normal LFTs (n = 196 360). (B+C) = Tested and abnormal LFTs (n = 31 672); Set B = Tested, abnormal LFTs but no diagnosis (n = 27 985); Set C = Tested, abnormal LFTs and liver diagnosis recorded (n = 3687). (C+D+E) = Liver diagnosis recorded; Set D = Tested, normal LFTs and liver diagnosis recorded (n = 4384); Set E = Not tested, liver diagnosis recorded (n =3965). This group of sets is further broken down into the proportions of patients with the common liver diagnoses. ALD = alcoholic liver disease. HBV = hepatitis B virus. HCV = hepatitis C virus.

Figure 2.

Figure 2.

Prevalence of NAFLD, ALD, HBV and HCV in different ethnic groups within the general population.

References

    1. Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375–82. e1–2. - PMC - PubMed
    1. Blachier M, Leleu H, Peck-Radosavljevic M, et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608. - PubMed
    1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–285. - PubMed
    1. Arnold DT, Bentham LM, Jacob RP, et al. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMC Fam Pract. 2011;12:9. - PMC - PubMed
    1. McLernon DJ, Dillon JF, Sullivan FM, et al. The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI) PLoS One. 2012;7(12):e50965. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources